Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Disarm Therapeutics
Disarm Therapeutics develops disease-modifying therapeutics for patients with axonal degeneration.
Sector
Subsector
Keywords
Location
total rounds
total raised
Aldeyra Therapeutics
Aldeyra Therapeutics is a biotechnology company that develops and commercializes next-generation medicines for immune-mediated diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
OcuTerra Therapeutics
OcuTerra Therapeutics is developing a novel eye drop to treat diabetic eye disease.
Sector
Subsector
Location
total rounds
total raised
Opsis Therapeutics
Opsis Therapeutics develops first-in-class treatments for retinal diseases.
Sector
Subsector
Location
Financials
Funding Rounds9
Number of Funding Rounds
Money Raised
Their latest funding was raised on 29.02.2024. Their latest round Venture - Series Unknown
Bios Partners
Bios Partners is a venture capital firm that invests in innovative early-stage and growth-stage biotech and medical device companies.
Sector
Subsector
Keywords
Location
count Of Investments
Visionary Venture Fund
Visionary is a venture capital firm that invests in emerging ophthalmology companies in medical devices and pharmaceuticals.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Mayewell Capital
Mayewell Capital is a healthcare-focused investment firm specializing in pharmaceuticals and biotechnology.
Sector
Subsector
Keywords
Location
count Of Investments
Alpine Visionary
Alpine Visionary Venture invests in companies at various stages of financing, from Series A to late-stage.
Sector
Subsector
count Of Investments
Bios Partners
Bios Partners is a venture capital firm that invests in innovative early-stage and growth-stage biotech and medical device companies.
Sector
Subsector
Keywords
Location
count Of Investments
Co-Investors
Investors18
Number of lead investors
Number of investors
Kaitai Capital
Kaitai Capital is a professional investment management organization.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Johnson & Johnson Innovation
Johnson & Johnson Innovation collaborates with innovators to incorporate science into healthcare solutions.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Marian Nakada
Marian Nakada, PhD, Vice President, Venture Investments, joined Johnson & Johnson Development Corporation (JJDC) in 2013. She is based in Boston, MA. Previously, Dr. Nakada was Vice President of Strategy & Operations and External Innovation for Johnson & Johnson’s Biotechnology CoE, where she helped drive the development and execution of the biotechnology strategy across Janssen R & D. In her role as External Innovation lead, she nurtured many productive partnerships with external partners in the biotech industry and helped build an external innovation network to complement internal research and support the execution of the Janssen R&D Biologics strategy. Dr. Nakada joined Centocor in 1990, as a scientist, performing basic research related to biologics for inflammatory and cardiovascular indications. In 2001, she took on the leadership of the newly formed Oncology Research group at Centocor. In 2007, Dr. Nakada joined the Business Development group where she participated in executing technology licenses for the Johnson & Johnson pharmaceuticals group. In that role, she identified and championed external technology opportunities to ensure that Centocor's technologies were competitive with the industry. Dr. Nakada has authored 62 peer reviewed publications and 14 book chapters and reviews. She has a BA in Biology from Harvard College and a PhD in Pharmacology from the University of Pennsylvania.
current job
Capital Community Angel Investors
Capital Community Angel Investors connects Michigan-based startups with early-stage capital.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders1
David Zacks
Co-Founder/CSO at ONL Therapeutics.
current job
organization founded
David Zacks